Milos Pesek
Prague, PR 12116, Czech Republic
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 70 publications
FGFR2 fusion as the key to targeted therapy - a case report with a diagnostic turning point.
Journal: Klinicka onkologie : casopis Ceske a Slovenske onkologicke spolecnosti
Published: August 28, 2026
Clinicopathologic features of KRAS G12C-mutated non-small cell lung carcinomas:insights from 279 retrospective cases.
Journal: Virchows Archiv : an international journal of pathology
Published: March 10, 2026
Omission of staging PET/CT linked to reduced survival in stage III non-small cell lung cancer: insights from the LUCAS project real-world data.
Journal: Translational lung cancer research
Published: January 30, 2024
High-Statistics Measurement of Collins and Sivers Asymmetries for Transversely Polarized Deuterons.
Journal: Physical review letters
Published: December 30, 2023
Final COMPASS Results on the Transverse-Spin-Dependent Azimuthal Asymmetries in the Pion-Induced Drell-Yan Process.
Journal: Physical review letters
Published: December 28, 2023
Patients with neuregulin 1 (NRG1) rearranged cancer are suitable for the theranostic approach and targeted therapy.
Journal: Klinicka onkologie : casopis Ceske a Slovenske onkologicke spolecnosti
Published: August 21, 2022
Detection and Quantification of ctDNA for Longitudinal Monitoring of Treatment in Non-Small Cell Lung Cancer Patients Using a Universal Mutant Detection Assay by Denaturing Capillary Electrophoresis.
Journal: Pathology oncology research : POR
Published: January 07, 2022
Combination of Circulating Tumour DNA and 18F-FDG PET/CT for Precision Monitoring of Therapy Response in Patients With Advanced Non-small Cell Lung Cancer: A Prospective Study.
Journal: Cancer genomics & proteomics
Published: November 16, 2021
Prognostic Value of EGFR Exon-20 Insertions in Czech Patients With Advanced Non-small Cell Lung Cancer.
Journal: Anticancer research
Published: September 20, 2021
Autologous dendritic cell-based immunotherapy (DCVAC/LuCa) and carboplatin/paclitaxel in advanced non-small cell lung cancer: A randomized, open-label, phase I/II trial.
Journal: Cancer treatment and research communications
Published: May 01, 2021
Comparison of Chemotherapeutic Regimens Frequently Used in Metastatic Non-squamous NSCLC Treatment.
Journal: Anticancer research
Published: March 31, 2021
Last Updated: 09/26/2026